BofA lowered the firm’s price target on Cooper Companies (COO) to $96 from $120 and keeps a Buy rating on the shares. Q2 revenue and EPS beat expectations, but the focus is on Cooper having lowered FY25 organic revenue growth guidance to 5%-7% from 6%-8% as it sees softening in two of its growth markets, contact lenses and fertility, the analyst tells investors. The lower CVI organic growth guidance was “a surprise” given March commentary, which could drive some near-term pressure on the stock, but it was “likely the right thing to do given the squishiness of peer results over the last several months” and it should put Cooper in a position to deliver upside to numbers, the analyst added.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COO:
- Cooper Companies price target lowered to $84 from $92 at Morgan Stanley
- JPMorgan downgrades Cooper Companies on lowered growth outlook
- Cooper Companies downgraded to Neutral from Overweight at JPMorgan
- Cooper Companies price target lowered to $97 from $107 at Baird
- Cooper Co: Strong Market Positioning and Growth Potential Highlighted by Robust Financial Performance and Strategic Initiatives
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue